Allumeros BioScience is a preclinical company, creating a new specific and targeted theranostic platform to treat the most difficult of cancer and cardiac conditions
We call this Photonanotherapy™
As the developer of Photonanotherapy™ (PNT) – Our purpose is to give clinicians new tools and therapies for a wide spectrum of difficult to treat conditions – providing the patient with a new alternative that can deliver better outcomes.
Photonanotherapy combines sophisticated photobiology with state of the art targeted nanomedicine, creating a new therapy with broad application across the therapeutic spectrum
PNT is a combination therapy, which can safely image, target and destroy specific diseased tissue
Allumeros will deliver a safe and highly effective, standardized, rapid and economic protocol that addresses multiple difficult to treat conditions across therapeutic segments
Developed by Allumeros these products will be delivered
through individual, segment focused operating businesses